Prestige Consumer Healthcare Price to Free Cash Flow Ratio 2010-2025 | PBH
Historical price to free cash flow ratio values for Prestige Consumer Healthcare (PBH) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Prestige Consumer Healthcare Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-04 | 84.79 | 17.45 | |
| 2025-03-31 | 85.97 | $4.86 | 17.70 |
| 2024-12-31 | 78.09 | $4.97 | 15.72 |
| 2024-09-30 | 72.10 | $5.08 | 14.20 |
| 2024-06-30 | 68.85 | $4.91 | 14.03 |
| 2024-03-31 | 72.56 | $4.77 | 15.21 |
| 2023-12-31 | 61.22 | $4.65 | 13.15 |
| 2023-09-30 | 57.19 | $4.33 | 13.20 |
| 2023-06-30 | 59.43 | $4.25 | 13.98 |
| 2023-03-31 | 62.63 | $4.45 | 14.08 |
| 2022-12-31 | 62.60 | $4.48 | 13.96 |
| 2022-09-30 | 49.83 | $4.67 | 10.66 |
| 2022-06-30 | 58.80 | $4.71 | 12.48 |
| 2022-03-31 | 52.94 | $4.92 | 10.75 |
| 2021-12-31 | 60.65 | $4.80 | 12.62 |
| 2021-09-30 | 56.11 | $4.42 | 12.70 |
| 2021-06-30 | 52.10 | $4.13 | 12.63 |
| 2021-03-31 | 44.08 | $4.22 | 10.45 |
| 2020-12-31 | 34.87 | $4.12 | 8.46 |
| 2020-09-30 | 36.42 | $4.33 | 8.41 |
| 2020-06-30 | 37.56 | $4.41 | 8.51 |
| 2020-03-31 | 36.68 | $3.96 | 9.26 |
| 2019-12-31 | 40.50 | $3.91 | 10.36 |
| 2019-09-30 | 34.69 | $3.62 | 9.58 |
| 2019-06-30 | 31.68 | $3.40 | 9.31 |
| 2019-03-31 | 29.91 | $3.43 | 8.71 |
| 2018-12-31 | 30.88 | $3.48 | 8.88 |
| 2018-09-30 | 37.89 | $3.48 | 10.89 |
| 2018-06-30 | 37.90 | $3.74 | 10.15 |
| 2018-03-31 | 33.30 | $3.69 | 9.02 |
| 2017-12-31 | 43.86 | $2.85 | 15.40 |
| 2017-09-30 | 49.47 | $2.80 | 17.67 |
| 2017-06-30 | 52.15 | $2.74 | 19.02 |
| 2017-03-31 | 54.87 | $2.73 | 20.08 |
| 2016-12-31 | 51.45 | $3.34 | 15.38 |
| 2016-09-30 | 47.67 | $3.45 | 13.83 |
| 2016-06-30 | 54.71 | $3.40 | 16.11 |
| 2016-03-31 | 52.72 | $3.26 | 16.19 |
| 2015-12-31 | 50.84 | $3.47 | 14.65 |
| 2015-09-30 | 44.60 | $3.66 | 12.18 |
| 2015-06-30 | 45.66 | $3.30 | 13.84 |
| 2015-03-31 | 42.36 | $3.04 | 13.93 |
| 2014-12-31 | 34.29 | $2.68 | 12.78 |
| 2014-09-30 | 31.97 | $2.12 | 15.10 |
| 2014-06-30 | 33.47 | $2.22 | 15.06 |
| 2014-03-31 | 26.91 | $2.08 | 12.95 |
| 2013-12-31 | 35.35 | $2.18 | 16.20 |
| 2013-09-30 | 29.49 | $2.42 | 12.18 |
| 2013-06-30 | 28.53 | $2.62 | 10.88 |
| 2013-03-31 | 25.15 | $2.48 | 10.16 |
| 2012-12-31 | 19.61 | $2.16 | 9.07 |
| 2012-09-30 | 16.60 | $1.74 | 9.55 |
| 2012-06-30 | 15.48 | $1.28 | 12.10 |
| 2012-03-31 | 17.11 | $1.32 | 12.99 |
| 2011-12-31 | 11.03 | $1.44 | 7.68 |
| 2011-09-30 | 8.86 | $1.51 | 5.85 |
| 2011-06-30 | 12.57 | $1.60 | 7.85 |
| 2011-03-31 | 11.26 | $1.71 | 6.59 |
| 2010-12-31 | 11.70 | $1.39 | 8.45 |
| 2010-09-30 | 9.68 | $1.23 | 7.87 |
| 2010-06-30 | 6.93 | $1.23 | 5.66 |
| 2010-03-31 | 8.81 | $1.17 | 7.51 |
| 2009-12-31 | 7.69 | $2.33 | 3.31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.194B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.634B | 27.97 |
| Boston Scientific (BSX) | United States | $152.531B | 38.19 |
| Stryker (SYK) | United States | $145.427B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $127.535B | 0.00 |
| Medtronic (MDT) | Ireland | $109.709B | 15.55 |
| Haleon (HLN) | United Kingdom | $49.754B | 28.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.468B | 0.00 |
| ResMed (RMD) | United States | $36.224B | 27.21 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Agilent Technologies (A) | United States | $32.148B | 20.88 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.748B | 89.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.431B | 15.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.172B | 11.67 |
| Baxter (BAX) | United States | $15.441B | 11.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.754B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.002B | 20.89 |
| Lantheus Holdings (LNTH) | United States | $5.375B | 13.56 |
| Perrigo (PRGO) | Ireland | $3.646B | 9.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.048B | 14.09 |
| LeMaitre Vascular (LMAT) | United States | $1.872B | 41.85 |
| AtriCure (ATRC) | United States | $1.719B | 0.00 |
| Neogen (NEOG) | United States | $1.302B | 16.67 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.110B | 24.97 |
| BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.986B | 12.60 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| CeriBell (CBLL) | United States | $0.612B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Owens & Minor (OMI) | United States | $0.517B | 4.29 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.326B | 11.98 |
| Aurora Cannabis (ACB) | Canada | $0.302B | 53.70 |
| Cresco Labs (CRLBF) | United States | $0.277B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.63 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanuwave Health (SNWV) | United States | $0.242B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.46 |
| Brainsway (BWAY) | Israel | $0.192B | 50.95 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.81 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.58 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.62 |
| Agape ATP (ATPC) | $0.081B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Nephros (NEPH) | United States | $0.035B | 46.71 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |